We have designed a new model to forecast sales of compounds in clinical development. We think that it does not suffice to predict the sales of one compound not taking account of the entire competitive landscape and their probability of success. We analyze each possible market scenario for the compound and elaborate the probability and the respective peak sales. Every single scenario on the market influences the strength of the compound and its pricing. This approach yields a comprehensive forecast for the peak sales of the compound in clinical development.